Clinical Challenges and Updates in Managing Seizure Clusters

Slides:



Advertisements
Similar presentations
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
Advertisements

The Nurse’s Role in Inflammatory Bowel Disease
NOACs In Long-term VTE Treatment: A State Of The Art Review
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Introducing JAK Inhibitors in Rheumatoid Arthritis
Expert Perspectives on Clinically Challenging Cases in Narcolepsy
The ABCs of AF.
Current Controversies in Multiple Sclerosis Management
Pediatric Antiepileptic Treatment Strategies
Epilepsy Treatment Across the Spectrum
Disclaimer. LEGAL AND POLICY CONSIDERATIONS OF NALOXONE FOR OPIOID TOXICITY REVERSAL.
What Comes Second?.
New Directions in iTTP.
Statin Selection in Special Patient Populations: A Case Challenge
Bone Biology and Osteoporosis: Back to the Basics
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
Challenges in Managing Progressive Multiple Sclerosis
IL-17 Inhibitors in the Management of Psoriatic Disease
Statins and New-Onset Diabetes REAL Updates and Clinical Implications
Are We Closer to Personalized Medicine in MS?
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Seizures in the Elderly: Treatment and Special Considerations
Management of Adolescents With Seizures
PrEP.
Practical Guidance on Using New Therapies for Relapsed/ Refractory Follicular Lymphoma and Chronic Lymphocytic Leukemia.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Program Goals Overview Glatiramer Acetate 3 Times a Week.
New LDL-C Lipid Targets
Charting Progress in MS Treatment:
Diagnosing Focal Epilepsy: A Clinical Case
Advancing the Treatment of IBD With Biologics
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Bone Biology and Osteoporosis: Back to the Basics
What's New on Interventions for Lower Limb Spasticity?
Treating CD30-Expressing Cutaneous T-Cell Lymphoma
Management of Systematic Lupus Erythematosus
Program Goals Overview Is NEDA a Reasonable Target?
WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?
What's New in Therapeutic Options for Moderate to Severe RA?
CMV in the HSCT Recipient
Identifying Strategies for Improving Outcomes in Patients With CTEPH
When Is Intrathecal Drug Delivery Appropriate?
Managing Age-Related Clinical Issues in Hemophilia
Considerations in Managing Seizures in Women
Program Goals Disclaimers Defining Refractory Seizures.
Updates in Anticoagulation: Key Sessions at ESC 2017
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Bone Biology and Osteoporosis: Back to the Basics
Incorporating Prostacyclins Into Practice
Practical Approaches for the Clinical Identification of Seizure Clusters.
Assessing the Burden of Hyperkalemia
Program Goal. Program Goal Disclaimer Overview.
The ABCs of AF.
Program Goals Overview Is NEDA a Reasonable Target?
Selecting Treatment Approaches in Hemophilia
Peanut Allergy Immunotherapy
When Is Intrathecal Drug Delivery Appropriate?
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Issues in Patients With Severe Epilepsy
AMD Therapy: Where Are We Now and Where Are We Going?
Assessing the Burden of Hyperkalemia
Incorporating New PAH Treatments Into Clinical Practice
Case Studies in Peanut Allergy Immunotherapy
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Exploring the Use of Adeno-Associated Virus for Gene Therapy
Ask the Psoriasis Expert
PCSK9 Inhibitors and Real-World Evidence
Presentation transcript:

Clinical Challenges and Updates in Managing Seizure Clusters

Disclaimer

Program Goals

Defining Seizure Clusters

Defining Seizure Clusters (cont)

Recognizing Seizure Clusters: Case Examples

Recognizing Seizure Clusters: Case Examples (cont)

How Frequent Are Seizure Clusters?

Factors That Increase Risk for Seizure Clusters

Recognizing Seizure Clusters

Triggers

Importance of Managing Clusters

Treatment for Seizure Clusters

Routes of Administration

Benzodiazepine Characteristics

Treatment of Seizure Clusters

Factors Affecting Design of Treatment for Seizure Clusters

Individualizing Therapy

Safety Considerations

Intranasal Administration

Emerging Strategies

Summary and Key Points

Abbreviations

References

References (cont)

References (cont)